文献速递心力衰竭与心肌病

运动多器官功能缺陷揭示射血分数保留心衰的临床与分子易感性

Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.
PubMed 文献 · Circulation · 2026-04-07

本研究在射血分数保留心衰(HFpEF)患者中应用有创心肺运动试验、代谢组学和基因组学,同时评估七种运动生理缺陷。结果显示,运动缺陷数量多与心血管事件或死亡风险显著升高相关,运动肺毛细血管楔压/心输出量斜率的代谢特征可预测MESA队列心衰事件。运动缺陷相关代谢基因与肥胖、肾功能不全和糖尿病共享遗传机制。

要点

  • HFpEF患者运动时存在多种心脏与心外功能缺陷复合表现。
  • 运动缺陷数量多与心血管事件或死亡风险增加相关。
  • 运动代谢特征有助于识别HFpEF亚表型和代谢机制。

核心结论

  • 器官特异性运动反应及其循环代谢特征与HFpEF发展和预后密切相关。

研究设计与样本

  • 纳入接受有创心肺运动试验(iCPET)的HFpEF患者队列,同时进行代谢物谱和基因组学分析。
  • 在MESA研究的6345例个体中随访约20年,评估代谢特征与心衰事件的关系。

主要发现

  • HFpEF iCPET队列年龄61.7±14.1岁,女性54%,BMI 30.6±6.7 kg/m2,表现出广泛的心脏与心外运动缺陷复合表现。
  • 具有≥5种运动缺陷者心血管事件或死亡风险HR 3.90(95%CI 1.74-8.75,P<0.0001)。
  • 运动PCWP/CO斜率的代谢特征在MESA队列中预测心衰事件HR 1.43/SD(95%CI 1.20-1.71,P<0.001)。
  • 所有iCPET运动缺陷代谢特征联合模型较传统HFpEF风险因素实现约20%的连续净重分类改善。
  • 运动缺陷相关基因在心衰GWAS中富集,并与肥胖、肾功能不全和糖尿病共享遗传易感性。

关键数值与推荐

  • 同时评估七种运动生理缺陷:运动每搏量和心率降低、PCWP/CO斜率陡增、肺血管阻力升高、肺机械限制、外周氧摄取受损、肥胖相关运动起始代谢代价增加。
  • ≥5种运动缺陷的心血管事件或死亡风险HR 3.90(95%CI 1.74-8.75,P<0.0001)。
  • 运动PCWP/CO斜率代谢特征预测心衰事件HR 1.43/SD(95%CI 1.20-1.71,P<0.001)。

临床怎么用

  • 运动负荷下综合评估多器官功能缺陷有助于判断HFpEF严重程度和预后。
  • 运动相关循环代谢特征可作为HFpEF风险分层和亚表型解析的辅助工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Exercise unmasks limitations in multi-organ system reserve capacity characteristic of heart failure with preserved ejection fraction (HFpEF). However, the metabolic and genetic underpinnings of exercise deficits, and their cumulative contribution to HFpEF severity and prognosis, remain incompletely understood. METHODS: We used invasive cardiopulmonary exercise testing (iCPET), metabolite profiling, and genomics to simultaneously characterize seven exercise physiologic deficits in HFpEF patients: reduced exercise stroke volume and heart rate, steep pulmonary capillary wedge pressure/cardiac output (PCWP/CO) slope, elevated pulmonary vascular resistance, pulmonary mechanical limitation to exercise, impaired peripheral oxygen extraction, and obesity-related exaggerated metabolic cost of initiating exercise. We first mapped the distribution, functional, and prognostic significance of these exercise deficits. We then applied LASSO regression to identify metabolite signatures of each exercise deficit, and measured the relation of these signatures with clinical-demographic features, cardiac magnetic resonance imaging, and incident HF in 6345 individuals in the Multi-Ethnic Study of Atherosclerosis (MESA) study with ≈20-year follow-up. Finally, we mapped deficit-implicated metabolites to tissue-specific genetic variation in ≈2M individuals with HF, and in the largest genome-wide association study (GWAS) studies of HFpEF comorbidities (obesity, renal disease, diabetes) to evaluate shared metabolic mechanisms of HFpEF pathophysiology. RESULTS: Our iCPET HFpEF cohort (61.7±14.1 years, 54% female, BMI 30.6±6.7 kg/m2 ) exhibited a broad range of compound cardiac and extra-cardiac exercise deficits. Individuals with ≥5 exercise deficits had a nearly 4-fold higher hazard of incident cardiovascular event or mortality (HR 3.90, 95% CI 1.74-8.75, P<0.0001). The metabolite signature of exercise PCWP/CO slope conferred a HR of 1.43 per SD increment, 95% CI 1.20-1.71, P<0.001 for incident HF in MESA. Addition of all iCPET deficit metabolic signatures in a single model yielded ≈20% continuous net reclassification improvement over traditional HFpEF risk factors. Genes implicated by the exercise deficit metabolome were enriched in the HF GWAS (≈2M) and shared with obesity, renal dysfunction, and diabetes, highlighting a lifelong shared predisposition to HF (including HFpEF) and its comorbidities. CONCLUSIONS: Organ-specific responses to exercise and their circulating metabolite signatures are strongly linked to HFpEF development and prognosis. These results offer a paradigm for parsing HFpEF subphenotypes and prioritizing metabolic mechanisms of HFpEF.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Landsteiner, Stolze, Peterson, et al. Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction. Circulation. 2026. PMID: 41944041. doi:10.1161/CIRCULATIONAHA.125.077579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。